-
Signature
-
/s/ Holly Youngwood under POA
-
Stock symbol
-
JPM
-
Transactions as of
-
Jan 13, 2024
-
Transactions value $
-
-$3,606,076
-
Form type
-
4
-
Date filed
-
1/16/2024, 07:10 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
JPM |
Common Stock |
Options Exercise |
$0 |
+16.1K |
+29.54% |
$0.00 |
70.6K |
Jan 13, 2024 |
Direct |
F1 |
transaction |
JPM |
Common Stock |
Options Exercise |
$0 |
+15.4K |
+21.84% |
$0.00 |
86K |
Jan 13, 2024 |
Direct |
F1 |
transaction |
JPM |
Common Stock |
Tax liability |
-$2.86M |
-16.6K |
-19.28% |
$172.61 |
69.5K |
Jan 13, 2024 |
Direct |
|
transaction |
JPM |
Common Stock |
Sale |
-$743K |
-4.46K |
-6.42% |
$166.72 |
65K |
Jan 16, 2024 |
Direct |
|
holding |
JPM |
Common Stock |
|
|
|
|
|
16.8K |
Jan 13, 2024 |
By Family Trust |
|
holding |
JPM |
Common Stock |
|
|
|
|
|
132K |
Jan 13, 2024 |
By GRATs |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
JPM |
Restricted Stock Units |
Options Exercise |
$0 |
-16.1K |
-100% |
$0.00* |
0 |
Jan 13, 2024 |
Common Stock |
16.1K |
|
Direct |
F1, F2 |
transaction |
JPM |
Restricted Stock Units |
Options Exercise |
$0 |
-15.4K |
-50% |
$0.00 |
15.4K |
Jan 13, 2024 |
Common Stock |
15.4K |
|
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: